You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 17911 - 17920 of 18911 results
  1. 7: CENTER FOR GLOBAL HEALTH (GCH)

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The Center for Global Health (CGH) leads the execution of the CDC’s global strategy; works in partnership to assist Ministries of Health to plan, manage effectively, and evaluate health programs; achieves U.S. Government program and international organization goals to improve health, including disease eradication and elimination targets; expandsCDC’s global health programs that focus on the le ...

    SBIRPhase IDepartment of Health and Human Services
  2. 001: The Development of Lateral Flow Immunochromatographic Devices to Detect Antibodies

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    During the past decade, several companies have developed lateral flow immunochromatographic devices to detect antibodies to individual communicable diseases. More recently, these platforms have also been adapted to detect specific antigens associated with these infections. These inexpensive point-of-care (POC) tests offer considerable advantages over conventional laboratory tests, since they can b ...

    SBIRPhase IDepartment of Health and Human Services
  3. 002: Development of a Blood Donor Screening Test to Prevent Transfusion Transmitted Babesiosis

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    Babesiosis is a potentially life-threatening zoonotic disease caused by intraerythrocytic protozoan parasites, which usually are tick-borne but are also transmissible by transfusion. Most infections are asymptomatic or only causemild disease but severe disease can occur in neonates, the elderly and immunocompromised patients. Babesiosis became nationally notifiable in January, 2011. Blood transf ...

    SBIRPhase IDepartment of Health and Human Services
  4. 8: NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES (NCBDDD)

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The mission of the CDC’s National Center on Birth Defects and Developmental Disabilities (NCBDDD) is to promote the health of babies, children and adults and enhance the potential for full, productive living. To achieve its mission, NCBDDD works to: Identify the causes of birth defects and developmental disabilities; helps children to develop and reach their full potential; and, promotes health ...

    SBIRPhase IDepartment of Health and Human Services
  5. 015: Development of an Assay to Rapidly Determine Folate Insufficiency in the Field

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    Many neural tube defects (NTD), serious birth defects of the brain and spine, can be prevented if a woman consumes folic acid daily before and during early pregnancy. Although mandatory folic acid fortification has increased blood folate concentrationsin the U.S., folate insufficiency remains a severe problem on a global scale. Determining the burden of folate insufficiency in a population can hel ...

    SBIRPhase IDepartment of Health and Human Services
  6. 9: NATIONAL CENTER FOR EMERGING ZOONOTIC AND INFECTIOUS DISEASES (NCEZID)

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The mission of the National Center for Emerging and Zoonotic Infectious Diseases aims to prevent disease, disability, and death caused by a wide range of infectious diseases. NCEZID focuses on diseases that have been around for many years, emerging diseases (those that are new or just recently identified), and zoonotic diseases (those spread from animals to people). NCEZID’s work is guided in pa ...

    SBIRPhase IDepartment of Health and Human Services
  7. 001: Vaccine Adverse Event Reporting System (VAERS) Application for Smartphone

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The Vaccine Adverse Event Reporting System (VAERS) serves as the nation’s frontline early warning system to detect vaccine safety concerns. To enhance and sustain reporting efficiency and improve data quality during routine and emergency situations, recent efforts have been made to advance the VAERS web reporting interface and increase web-based reporting. Although web-based reporting can be don ...

    SBIRPhase IDepartment of Health and Human Services
  8. 002: Development of Rapid, Point-of-Care Tests for Diagnosis of Fungal Infections

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    Fungi are some of the most common causes of major HIV-related opportunistic infections in the world. Cryptococcal meningitis is estimated to kill more HIV-infected persons than tuberculosis in sub-Saharan Africa. Pneumocystis pneumonia is the most common cause of acute pneumonia in most areas; histoplasmosis is extremely common in Central and South America, and penicilliosis marneffei is highly en ...

    SBIRPhase IDepartment of Health and Human Services
  9. 10: NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TB PREVENTION (NCHHSTP)

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The mission of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) is to maximize public health and safety nationally and internationally through the elimination, prevention, and control of disease, disability, and death caused by HIV/AIDS, Viral Hepatitis, other Sexually Transmitted Diseases, and Tuberculosis. NCHHSTP Web site: http://www.cdc.gov/nchhstp/

    SBIRPhase IDepartment of Health and Human Services
  10. 031: Testing the Efficacy of HIV Prevention Strategies in Nonhuman Primate Models

    Release Date: 08-25-2011Open Date: 08-25-2011Due Date: 11-07-2011Close Date: 11-07-2011

    The field of HIV prevention has recently gained two new biomedical preventions: 1) a partially effective HIV vaccine, RV-144 delivered parenterally, and 2) partially effective pre-exposure prophylaxis (PrEP) in the form of a microbicide delivered as a vaginal gel, or as a daily, oral tablet. These preventions, while not yet approved for general use, are - either in the same form or in modified for ...

    SBIRPhase IDepartment of Health and Human Services
US Flag An Official Website of the United States Government